D9820

Anti-DOCK1 (C-terminal region) antibody produced in rabbit

~1.5 mg/mL, affinity isolated antibody, buffered aqueous solution

• 同義詞: Anti-DOCK180, Anti-Dedicator of cytokinesis 1, Anti-Downstream of CRK-binding protein, 180-KD
• 分類程式碼代碼: 12352202
• NACRES: NA.41

屬性

• 生物源: rabbit
• 共軛: unconjugated
• 抗體表格: affinity isolated antibody
• 抗體產品種類: primary antibodies
• 無性繁殖: polyclonal
• 形狀: buffered aqueous solution
• 分子量: antigen ~180 kDa
• 物種活性: rat, mouse, human
• 濃度: ~1.5 mg/mL
• 技術: indirect immunofluorescence: 5-10 μg/mL using NIH-3T3 cells; western blot: 2-4 μg/mL using HeLa cell lysate and PC12 cell lysate
• UniProt登錄號: Q14185
• 運輸包裝: dry ice
• 儲存溫度: −20°C
• 目標翻譯後修改: unmodified
• 基因資訊: human ... DOCK1(1793)

描述

一般說明

Dedicator of cytokinesis protein 1 (DOCK1), also termed as DOCK180, is a member of a family of guanine nucleotide exchange factors (GEF). The DOCK1 gene is mapped to human chromosome 10q26.2.

特異性

Anti-DOCK1 (C-terminal region) specifically recognizes human, rat, and mouse DOCK1.

應用

Anti-DOCK1 (C-terminal region) antibody produced in rabbit has been used in immunoblotting and immunofluorescence.

生化／生理作用

Dedicator of cytokinesis protein 1 (DOCK1) acts as an activator of Rac and is involved in cytoskeletal reorganization and cell migration. By activating the β1 and αvβ5 integrins, DOCK1 regulates cell motility, filopodia formation, and phagocytosis. It is involved in the integrin signaling through the adapter molecule crk (Crk)- (p130) Crk-associated substrate p130 Cas complex. Its localization at focal adhesions induces the phosphorylation of p130Cas. DOCK1 forms a complex with engulfment and cell motility protein 1 (ELMO1) that functions as a bipartite guanine nucleotide exchange factor (GEF) for Rac and inhibits ubiquitylation of DOCK1. In mammalian cells, the CrkII-ELMO1-DOCK1 complex has been shown to promote phagocytosis. DOCK1 has been suggested to play a central role in netrin signaling during neuronal development by mediating the attractive responses by neurons to netrin-1. It mediates morphological changes such as integrin-mediated cell spreading and nerve growth factor (NGF)-induced neurite outgrowth. DOCK1 has been found to undergo ubiquitination and proteasome-dependent degradation, a process enhanced in response to epidermal growth factor (EGF), Crk, and adhesion-dependent signals.

外觀

Solution in 0.01 M phos­phate buffered saline, pH 7.4, containing 15 mM sodium azide.

儲存和穩定性

Store at –20 °C. For continuous use, the product may be stored at 2–8 °C for up to one month. For extended storage, freeze in working aliquots at –20 °C. Repeated freezing and thawing, or storage in “frost-free” freezers, is not recommended. If slight turbidity occurs upon prolonged storage, clarify the solution by centrifugation before use. Working dilutions should be discarded if not used within 12 hours.

免責聲明

Unless otherwise stated in our catalog, our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.